KyungdongPharm

경동제약 · 011040

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$110.9M (₩153.1B)

Overview

KyungdongPharm makes prescription and over-the-counter medicines supplied to patients and healthcare providers in South Korea.

It is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. The company operates through a parent entity alongside several unlisted subsidiaries, giving it a consolidated group structure.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$142.2M

▲ +1.2% YoY

Operating profit · FY2025

US$5.6M

▲ +192.2% YoY

Net income · FY2025

US$6.1M

▲ +55.1% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$117.9M(₩162.7B)	US$140.5M(₩193.9B)	US$142.2M(₩196.3B)
Operating profit	−US$18.1M(−₩25B)	US$1.9M(₩2.6B)	US$5.6M(₩7.7B)
Net income	−US$15M(−₩20.7B)	US$3.9M(₩5.4B)	US$6.1M(₩8.5B)

Revenue

FY2023US$117.9M
FY2024US$140.5M
FY2025US$142.2M

Operating profit

FY2023−US$18.1M
FY2024US$1.9M
FY2025US$5.6M

Net income

FY2023−US$15M
FY2024US$3.9M
FY2025US$6.1M

Key ratios (FY2025)

ROE

3.7%

Debt/Eq

40.6%

Op. margin

3.9%

Net margin

4.3%

Rev. YoY

▲ +1.2%

Why it matters

The company consolidates seven subsidiaries under its group structure, none of which are separately listed on a public exchange.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?